Out of the 96 cases diagnosed with oral or pharyngeal cancer in our study, (64.6%) were males, whereas females comprised (35.4%). When it comes to the relative distribution which refers to the relationship between the gender and the tumour location, we found out that the male gender is dominant in all tumour locations except the hypopharynx where the females were most recurrent (75%) see (Table 1). The mean age was 57 years old. The most common tumour location was oral by (58.3%), then Nasopharynx, Oropharynx, Hypopharynx by (22.9%, 14.6%, 4.2%) respectively.
in regards to the chief complaints in oral cancer, oral mass followed by the ulcer were the most frequent complaints (62.5%, 26.7%) respectively.
Furthermore, the most common chief complaint in nasopharynx cases was neck mass (68.2%), compared to Dysphagia in both of oropharynx and hypopharynx by (50%) each. All the additional chief complaints encountered are shown in (Table 2).
Smoker patients in the oral tumour represented (55.3%) of the total sample. Moreover, smokers with nasopharyngeal or hypopharyngeal cancer were 50%. Lastly, (71.4%) of oropharyngeal tumour individuals were smokers.
(50%) of the patients with oral cancer showed an extra complaint which was mainly weight loss with (39.2%) followed by reflex otalgia with (35.7%). Moreover, (68.2%) of the symptomatic nasopharyngeal cancer had reflex otalgia, night sweat and rhinorrhea as extra complaints with (13.3%) each. In the group of oropharyngeal cancer, (78.5%) of patients showed reflex otalgia and weight loss with (45.4%). Lastly, hypopharyngeal cancer patients demonstrated weight loss as a main extra complaint with (75%).
concerning tumour location of the sample studied we found out:
- Oral tumour: the lower lip tumour was the most encountered by (33.9%) followed by the oral tongue (28.6%), Hard palate (10.7%), Buccal mucosa (10.7%), Retromolar trigone (7.1%), Mouth floor (5.4%), Alveolar ridge (1.8%) and upper lip (1.8%) respectively.
- Oropharynx: tonsil was the most frequent site (50%), then Tongue base (35.7%), Soft palate (7.1%) and Lateral pharyngeal wall (7.1%) respectively.
- Hypopharynx: Post-cricoid region (50%), Piriform sinus (25%) and Posterior pharyngeal wall (25%).
- 90% of Nasopharynx tumours were in the Rosenmuller fossa.
The most common histological type in all previously mentioned tumour was Squamous cell carcinoma (SCC) by (92.9%) for oral tumour, (90.9%) for Nasopharynx, (85.7%) in regards to the oropharynx, and all the hypopharynx tumour were SCC. Other histologic manifestations including adenoid cystic carcinoma, lymphoma, rhabdomyosarcoma and Adenosquamous cell carcinoma with their percentage are shown in (table 3).
The TNM classification for SCC diagnosed cases:
Patients with SCC of oral cancer, (40.4%) of the total were considered as T2, while both T1 and T4a were (19.2%), T3 (17.3%), and finally T4b (3.8%).
on the other hand, Nasopharynx statistics showed T2 (70%), whereas T1 was (25%), and the less common was T3 by (5%).
about oropharynx data showed T2 and T4a as the most common (41.7% each), in addition to T1 and T3 as the less common (8.3% each).
finally, hypopharynx T1 (50%), T2 and T4a were (25% each).
The metastases to the cervical lymph nodes in the oral tumour were N0 (40.1%), N2c (25%), N1 (23.1%), N2a (5.8%), N3 (3.8%), N2b (1.9%). While nasopharynx statistics showed (52.6%) for N1, N2a (26.3%), N0 and N3 (10.5% each). Whereas the node classification for the oropharynx was (25%) for each of N0, N1 and N3. On the other hand, N2c was (16.7%), N2a (8.3%). Finally, the hypopharynx tumour node classified as (25%) for each of N0, N1, N2a and N2c.
The distant metastases are shown in (Table 4).
Statistical inference:
We used the chi-square test to study the relationship between the clinical staging of the tumour and the metastases to the cervical lymph nodes. Based on that we concluded that there is a statistically significant association between T and N in the oral tumour, while this association was not found in the other tumour locations. All the data are shown in (table 5).